Immunotherapeutic approaches to cancer are getting a lot of laboratory attention. As the techniques become more refined over the coming five to ten years, I predict that they will become increasingly important for longevity, wiping out one of the biggest killers that prevent us from living longer. As the curves above show, conventional therapies have a survival rate of close to zero. Immunotherapy allows for the curve to level off. All of this is great news, but it’s not the end-all answer to longevity; it’s been calculated that even if cancer were eradicated, it would only extend average life
...more
